Skip to content

Impact of tDCS on Cerebral Autoregulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01865604
Enrollment
60
Registered
2013-05-31
Start date
2012-04-30
Completion date
2014-03-31
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Microangiopathy, CADASIL, Migraine With Aura, ICA Stenosis

Brief summary

The aim of the study is to investigate whether there is a polarity-specific influence of tDCS on cerebral vasomotor reactivity monitored by transcranial doppler sonography.

Interventions

DEVICEAnodal tDCS
DEVICEsham tDCS

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. severe cerebral Microangiopathy 2. NOTCH3 carrier 3. Migraine with aura (IHS Classification ICHD-II) 4. Stenosis \>80%, ECST-Criteria

Exclusion criteria

* seizure disorder * history of severe alcohol or drug abuse, psychiatric illness like severe depression, poor motivational capacity * dementia (1+2) history of stroke in past 3 months (3) migraine prophylaxis (4) contralateral stenosis \>50%,

Design outcomes

Primary

MeasureTime frameDescription
Cerebral vasomotor reactivity assessed by transcranial Dopplersonographyon 3 days within 12 weekscomparing cerebral vasomotor reactivity at baseline and after anodal/cathodal/sham stimulation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026